Tuesday's Small-Cap Winners & Losers

Stock quotes in this article: ADLR , GSK , AVNC , SURG , IRIX , TLCV , AMRN  

Updated from 2:01 p.m. EDT

Health stocks dominated small-cap movers Tuesday, and leading the way was Adolor(ADLR Quote), plummeting more than 58% after a late-phase study of alvimopan, a gastrointestinal treatment, induced higher (but statistically insignificant) rates of adverse cardiovascular events and cases of skin lesions than a placebo. Adolor's partner, GlaxoSmithKline(GSK Quote), halted other studies involving the compound. Adolor shares closed down $5.12 to $3.60. GlaxoSmithKline shares gave up 17 cents to $55.95.

Advancis Pharmaceutical(AVNC Quote), based in Maryland, plans to sell around 10.2 million of its shares, along with five-year warrants to buy some 7.6 million more for $2.27 apiece, at $2.36 per unit (each consisting of one share and a warrant for 0.75 shares). Gross proceeds should total about $24 million. Shares slid 9 cents, or 3.6%, to $2.41.

Meanwhile, shares of both Synergetics USA(SURG Quote) and Iridex(IRIX Quote) were leaping after the medical-equipment makers settled all of Iridex's patent-infringement claims regarding its laser-probe technology. Synergetics is required to pay Iridex $2.5 million on April 16, as well as $800,000 annually until 2012. But under a new agreement, Synergetics is also now allowed to make "various laser disposables" for a potential of more than $3 million in revenue over the next five years. Its shares soared 87 cents, or 21.1%, to $4.99. Iridex stock climbed 43 cents, or 6.5%, to $7.05.

  • Loading Comments...
  •  
< Previous
1 2

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,297.91 1,093.48 2,137.89 32.01
Oil *
78.36
DOWN
12.01
UP
1.99
DOWN
0.55
DOWN
0.30
10 Yr
3.20%
SPDR Gold
115.34
-0.12%
+0.18%
-0.03%
-0.93%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services